Berberine Repairs Intestinal Mucosal Barrier by Targeting HSP90AA1 and MAPK14
{{output}}
Background: Berberine (BBR), a key compound in Coptis chinensis, has broad pharmacological properties, though its specific Crohn's disease (CD) targets and mechanisms are undefined. ... ...
